RN
ReNeuron Group plc
RNUGF · OTC
$0.00 +0.00% (+$0.00)
Market Cap £47.1K
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
2/9Valuation
100 /100
Cheap P/S 0.09x
P/B 0.01x
P/E N/A
Growth
0 /100
Declining Rev. growth 55.62%
Book val. growth 27.41%
EPS growth N/A
Profitability
0 /100
Weak Gross margin 742.08%
Net margin 1,020.38%
FCF margin 1,453.58%
Quality
1 /100
Poor ROIC 105.51%
ROA 56.07%
Asset turnover 0.05x
Debt
69 /100
Low Debt/Equity 0.08x
Current ratio 2.05x
Int. coverage -331.85x
Stability
51 /100
Moderate Beta 1.04x
Rev. volatility 81.77%
Profitable years 0
Bulios Scoring opisuje jakość i historię firmy, a nie przyszły zwrot. Wysoki wynik to nie sygnał zakupu. Dowiedz się więcej
Zapytaj StockBota o RNUGF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Iain Gladstone Ross
Employees
26
Headquarters
Pencoed
Nadchodzące wydarzenia
11 LIS
Earnings
Upcoming earnings report